Abstract: A composition for a resin used in additive manufacturing of a biocompatible medical device is disclosed. The composition includes a photo-initiator, a light attenuator, and a light absorber. The light attenuator limits a transmission of light that activates the photo-initiator in a build direction of the additive manufacturing including by scattering at least some of the light in a second direction different from the build direction. The light absorber absorbs at least some of the light scattered in the second direction by the light attenuator. The light absorber is one or more of a benzophenone, an oxybenzone, or an avobenzone.

Abstract: A light polymerizable composition for use in the additive manufacturing of medical devices may include a first photo-initiator and a second photo-initiator. The first photo-initiator activates to initiate curing of the composition when exposed to light of a first wavelength in an additive manufacturing device and the second photo-initiator limits the transmission of the light of the first wavelength that activates the first photo-initiator in the additive manufacturing device. The second photo-initiator is activated to further cure the composition when exposed to a light of a second wavelength different from the first wavelength by activating the second photo-initiator to produce free radicals at a higher rate when exposed to the light of the second wavelength than when exposed to the light of the first wavelength.

Abstract: A light polymerizable composition for use in the additive manufacturing of medical devices may include a first photo-initiator and a second photo-initiator. The first photo-initiator activates to initiate curing of the composition when exposed to light of a first wavelength in an additive manufacturing device and the second photo-initiator limits the transmission of the light of the first wavelength that activates the first photo-initiator in the additive manufacturing device. The second photo-initiator is activated to further cure the composition when exposed to a light of a second wavelength different from the first wavelength by activating the second photo-initiator to produce free radicals at a higher rate when exposed to the light of the second wavelength than when exposed to the light of the first wavelength.

Abstract: A method for ingesting data artifacts into a recovery pod may include: identifying, by a first controller, a data artifact for ingestion; pulling, by the first controller, the data artifacts into the first datastore; confirming, by second controller, that a first airlock between the first zone and the second zone and a second airlock between a third zone and the second zone are closed; opening, by the second controller, the first airlock; identifying, by the second controller, the data artifacts in the first datastore; pulling, by the second controller, the data artifacts into a second datastore; confirming that the first airlock and the second airlock are closed; opening, by the second controller, the second airlock; identifying, by a third controller, the data artifacts in the second zone datastore; pulling, by the third controller, the data artifacts into a third zone datastore; and closing, by the second controller, the second airlock.

Abstract: The present specification discloses one or more anti-oncogenic phytochemicals comprising one or more compounds of chemical formula I: wherein R1is independently selected from H, CH3 or C2H5or is not present; R2 is independently selected from H, CH3 or C2H5 or is not present; provided that when R1 is not present, R2 is selected from H, CH3 or C2H5 and when R2 is not present R1 is selected from H, CH3 or C2H5: R3 is a C4-40 straight or branched chain, alkyl or alkylene and optionally substituted with one or more groups independently selected from CH3, OH, SH, NH2, OMe, OEt, N(H)Me and NMe2; and X is independently selected from CH3, OH, SH, NH2, OMe, OEt, N(H)Me, and NMe2, as well as, extracts, pharmaceutical compositions and medicaments comprising the one or more anti-oncogenic phytochemicals disclosed herein, methods of preparing such extracts, pharmaceutical compositions, and medicaments comprising the one or more anti-oncogenic phytochemicals , and methods and uses for treating a neoplasm or a cancer usi

Abstract: The present specification discloses one or more anti-oncogenic phytochemicals, extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals disclosed herein, methods of preparing extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals, extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals prepared according to methods disclosed herein, and methods and uses for treating a neoplasm or a cancer using one or more anti-oncogenic phytochemicals as well as extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals disclosed herein.

Abstract: A process for additive manufacturing of a resorbable implant to be implanted into a patient includes providing a biocompatible resin including a liquid light-polymerizable material that is resorbable after polymerization and an initiator. The process further includes actuating an additive manufacturing apparatus to expose an amount of the biocompatible resin to light to at least partially cure the exposed amount of biocompatible resin to form a layer of the resorbable implant and actuating the additive manufacturing apparatus to expose at least some additional amount of biocompatible resin to light to at least partially cure the exposed additional amount of biocompatible resin to form an additional layer of the resorbable implant and to at least partially overcure previously cured layers to cause at least some interlayer binding between the previously cured layers and the additional layer.

Abstract: The present specification discloses one or more anti-oncogenic phytochemicals, extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals disclosed herein, methods of preparing extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals, extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals prepared according to methods disclosed herein, and methods and uses for treating a neoplasm or a cancer using one or more anti-oncogenic phytochemicals as well as extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals disclosed herein.

Abstract: In one aspect, a water conservation apparatus is provided that includes a diverter having an inlet for being connected to a water supply, a primary outlet, and a secondary outlet. The apparatus includes an elongate water storage tank and a supply conduit configured to connect the secondary outlet of the diverter to the water storage tank. The elongate water storage tank has a height and a width perpendicular to the height that is less than the height so that the water from the secondary outlet of the diverter forms a column within the tank. The apparatus further includes a tap having an outlet and a valve, the valve having a closed position that inhibits water flow from the water tank to the outlet and an open position that permits water to be driven out of the outlet by the column of water in the tank.

Abstract: A method for ingesting data artifacts into a recovery pod may include: identifying, by a first controller, a data artifact for ingestion; pulling, by the first controller, the data artifacts into the first datastore; confirming, by second controller, that a first airlock between the first zone and the second zone and a second airlock between a third zone and the second zone are closed; opening, by the second controller, the first airlock; identifying, by the second controller, the data artifacts in the first datastore; pulling, by the second controller, the data artifacts into a second datastore; confirming that the first airlock and the second airlock are closed; opening, by the second controller, the second airlock; identifying, by a third controller, the data artifacts in the second zone datastore; pulling, by the third controller, the data artifacts into a third zone datastore; and closing, by the second controller, the second airlock.

Abstract: A system that coordinates delivery of a package from a first location to a second location is described. The system includes a delivery coordination server and a first device located at a first location, a second device located at a second location, and a third device connected via a communication network. A first arrival notification associated with a package is received from a first device. A second arrival notification regarding an arrival of the package at the first location is sent to a second device. A pick-up notification is received from the second device indicating an intended time of pick-up of the package from the first location. Navigation data is sent to the second device at the intended time of pick-up. A delivery confirmation notification is received from the first device and/or the second device indicating that the package has been delivered to or picked up from the first location.

Abstract: In one aspect, a water conservation apparatus is provided that includes a diverter having an inlet for being connected to a water supply, a primary outlet, and a secondary outlet. The apparatus includes an elongate water storage tank and a supply conduit configured to connect the secondary outlet of the diverter to the water storage tank. The elongate water storage tank has a height and a width perpendicular to the height that is less than the height so that the water from the secondary outlet of the diverter forms a column within the tank. The apparatus further includes a tap having an outlet and a valve, the valve having a closed position that inhibits water flow from the water tank to the outlet and an open position that permits water to be driven out of the outlet by the column of water in the tank.

Abstract: The disclosure relates to a class of diol-based, unsaturated aliphatic polyesters that biodegrade into monomers capable of mitigating infection. These poly(diol fumarates) (PDFs) and poly(diol fumarate-co-succinates) (PDFSs), can be crosslinked to form networks of scaffolds with antimicrobial degradation products. Both the diol carbon length and the degree of available double bonds are tunable, resulting in a highly controllable class of antimicrobial polymers useful for cell scaffolds and drug delivery systems and devices.

Abstract: A dual primary deicing system for a rotary-wing aircraft, according to an exemplary aspect of the present disclosure includes, among other things, an electrothermal heating element system; and a controller in communication with said electrothermal heating element, said controller communicating a heating cycle to said electrothermal heating element system, said heating cycle defining a first electric pulse train associated with a main rotor blade assembly.

Abstract: A light-polymerizable composition for additive manufacturing of resorbable scaffolds and implants comprising a biocompatible resin. The biocompatible resin includes a combination of photo-initiators or a dye-initiator package tailored to manufacture implants with the desired physical and chemical properties. A dye or other constituent controls between layer (z) resolution of the manufactured part built in an additive manufacturing device. A light absorber or other constituent controls within layer (x-y) resolution of the manufactured part.

Abstract: The disclosure relates to a class of diol-based, unsaturated aliphatic polyesters that biodegrade into monomers capable of mitigating infection. These poly(diol fumarates) (PDFs) and poly(diol fumarate-co-succinates) (PDFSs), can be crosslinked to form networks of scaffolds with antimicrobial degradation products. Both the diol carbon length and the degree of available double bonds are tunable, resulting in a highly controllable class of antimicrobial polymers useful for cell scaffolds and drug delivery systems and devices.

Abstract: A light-polymerizable composition for additive manufacturing of resorbable scaffolds and implants comprising a biocompatible resin. The biocompatible resin includes a combination of photo-initiators or a dye-initiator package tailored to manufacture implants with the desired physical and chemical properties. A dye or other constituent controls between layer (z) resolution of the manufactured part built in an additive manufacturing device. A light absorber or other constituent controls within layer (x-y) resolution of the manufactured part.

Abstract: A method, apparatus and system for registering, photographing, tracking and managing surgical instruments and equipment by multiple users. An integrated check-in & check-out station is provided to check medical equipment into a health care facility, take photos, provide labels, and create a cloud based record of the equipment delivered, including photo(s) of equipment checked in. The record created is accessible by the medical equipment vendor, or any linked vendor, and by medical facility staff users, from any location. The contents of any equipment tray can be identified simply by scanning the code on the label printed at the check-in station and applied to the equipment tray.

Abstract: A process for additive manufacturing of a resorbable implant to be implanted into a patient includes providing a biocompatible resin including a liquid light-polymerizable material that is resorbable after polymerization and an initiator. The process further includes actuating an additive manufacturing apparatus to expose an amount of the biocompatible resin to light to at least partially cure the exposed amount of biocompatible resin to form a layer of the resorbable implant and actuating the additive manufacturing apparatus to expose at least some additional amount of biocompatible resin to light to at least partially cure the exposed additional amount of biocompatible resin to form an additional layer of the resorbable implant and to at least partially overcure previously cured layers to cause at least some interlayer binding between the previously cured layers and the additional layer.

Abstract: A dual primary deicing system for a rotary-wing aircraft, according to an exemplary aspect of the present disclosure includes, among other things, an electrothermal heating element system; and a controller in communication with said electrothermal heating element, said controller communicating a heating cycle to said electrothermal heating element system, said heating cycle defining a first electric pulse train associated with a main rotor blade assembly.